India may lose Rs 6,300 Crores in pharma exports
Advertisement
Advertisement
India is set to suffer at least $1 billion (Rs 6,300 crore) of losses in pharmaceutical exports this fiscal year after the European Commission banned nearly 700 generic drugs after GVK Bio allegedly manipulated clinical trials.Director general of Pharmaceuticals Export Promotion Council PV Appaji said, "Majority of those 700 generic drugs are either produced or sourced by the domestic and multinational
A
Appaji said that the commerce ministry is scheduled to organize discussions with the stakeholders in the next couple of days and may lodge a compliant with the global agencies against the
India reportedly exported $15.2 billion or Rs 94,275 crore of pharmaceutical products in 2014-15, with European Union accounting for a fifth or $3 billion.
Advertisement
Image credit: Indiatimes
Advertisement
- I got a $40K raise using this 30-second strategy. It made me realize loud work, not hard work, always wins.
- Qatar Airways' new CEO explains why it's sticking with the Airbus A380 as other airlines retire the costly superjumbo
- Prince Harry and Meghan found out about Kate Middleton's cancer diagnosis on TV like everyone else, report says
- Shapoorji Pallonji’s Afcons Infra files DRHP for ₹7,000 crore IPO
- Water crisis affects businesses across Bengaluru; Is there room for cautious optimism?
- BenQ Zowie EC2-CW review – Premium wireless mouse for gamers
- Banks' GNPAs set to improve further to 2.1 pc by FY25: Care Ratings
- FPIs make remarkable comeback, infuse ₹2 lakh cr in FY24